AzTrials
AzTrials

Executive Function Deficits (EFD)NCT07085403

Let's CO-OPerate! Together we Are Stronger

A study testing Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach in people with Executive Function Deficits (EFD) and Developmental Coordination Disorder, run by Hopitaux de Saint-Maurice at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this replicated single case experimental study using a randomized multiple baseline design across participants and goals is to enable children/adolescents (aged 8-16 years) with developmental coordination disorders and/or executive function deficits following an acquired or congenital brain injury, to… Read more about this study

Who is it for?
Ages 8 to 16 years
What is being tested?
Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteFrance
Study dates
1 Sep 2025to 1 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children/adolescents (8-16 years old) with coordination disorders and/or executive function deficits, following a acquired brain injury more than 3 months ago or a congenital brain lesion or a neurodevelopmental disorder.
  • Executive function deficits as assessed by neuropsychological tests (standardised tests and/or questionnaires) and/or coordination disorders as assessed by neuropsychological tests (standardised tests and/or questionnaires).
  • Vision and hearing normal or sufficient to communicate effectively (with appropriate correction where necessary).
  • Cognitive, behavioural and expressive/receptive communication skills enabling them to identify goals and participate actively in the CO-OP intervention process.
  • Membership of a health insurance scheme or beneficiary.
  • Agreement of the child/adolescent and informed consent expressed by at least one of the holders of parental authority.
Show all 12Show fewer
  • Non-inclusion criteria :
  • Children/adolescents who do not meet the inclusion criteria.
  • Children/adolescents and/or parents non-French-speaking.
  • Presenting intellectual difficulties, or severe problems of comprehension, memory or attention, as described in the CO-OP recommendations.
  • A diagnosed severe anxiety-depressive disorder that is not compatible with participation in the study.
  • Inability to remain involved until the end of the CO-OP intervention phase (e.g. planned move).

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Helene LEBRAULT, OT, PhD contact

+0033143966682

helene.lebrault@ght94n.fr

France1 site
  • Hôpitaux Paris-Est Val-de-Marne

    Saint-Maurice, Île-de-France Region, 94410

    Helene LEBRAULT, OT, PhD, +0033607659198, helene.lebrault@ght94n.fr

Other trials in France

About this study

Official title: Let's CO-OPerate! Together we Are Stronger: Exploring the Effectiveness of the CO-OP Cognitive Problem-solving Approach in the Context of an Intensive Group Rehabilitation Training for a Paediatric Population With Executive Function Deficits and/or Developmental Coordination Disorders Following Brain Injury

The goal of this replicated single case experimental study using a randomized multiple baseline design across participants and goals is to enable children/adolescents (aged 8-16 years) with developmental coordination disorders and/or executive function deficits following an acquired or congenital brain injury, to achieve their occupational goals. The aim is to make them more independents and autonomous in their daily lives. To achieve this, we're going to offer them an intensive group CO-OP (Cognitive Orientation to daily Occupational Performance Approach) rehabilitation training, and actively involving the parents. The main questions it aims to answer are:

  • To evaluate the improvement in occupational performance* (and its maintenance over time) following intervention using the CO-OP Approach. *Occupational performance is a person's ability to choose, organize and engage in meaningful occupations that give them satisfaction. These occupations, determined by culture and corresponding to their age group, enable them to take care of themselves, have fun and contribute to the social and economic fabric of the community.
  • To gather parents' experiences of supporting their child during the CO-OP intervention and its follow-up phase.

Participants will be asked to identify 3 goals that they would like to achieve with the CO-OP Approach. The CO-OP intervention will take the form of two half-days a week for 5 weeks, with 1 hour 30 minutes of individual CO-OP sessions and 1 hour 30 minutes of group sessions.

Being tested
Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach
Keywords
paediatric rehabilitation, occupational therapy, executive function deficits, developmental coordination disorder, acquired brain injury, fetus and neonate brain injury, Cognitive Orientation to daily Occupational Performance (CO--OP), intensive training, individual and group rehabilitation
Medical subject headings
Motor Skills Disorders, Brain Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approachOther

    Cognitive Orientation to daily Occupational Performance (CO-OP; CO-OP approach) is a performance-based treatment approach for children and adults who experience difficulties performing the skills they want to, need, to or are expected to perform. CO-OP is a specifically tailored, active client-centered approach that engages the individual at the meta-cognitive level to solve performance problems. Focused on enabling success, the CO-OP approach employs collaborative goal setting, dynamic performance analysis, cognitive strategy use, guided discovery, and enabling principles. These elements, all considered essential to the CO-OP Approach, are situated within a structured intervention format, and may involve the parent/significant other as appropriate.

Study groups in NCT07085403
Study groupRoleWhat they receive
COOP experimental armExperimentalNot described
Receives: Other: Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Goal Attainment Scale (GAS)

    The Goal Attainment Scale (GAS) is a criterion--referenced measure used to quantify the degree to which personal goals are achieved. GAS methodology consists in:

    • Defining a rehabilitation goal;
    • Choosing an observable behaviour that reflects the degree of goal attainment;
    • Defining the patient's initial level with respect to the goal;
    • Ranging from a ''no change'' to a ''much better than expected outcome'');
    • Evaluating the patient after a defined time interval;
    • Calculating the overall attainment score for all the rehabilitation goals. A five-point scale will be used: "-2" is the initial pretreatment level; "-1" represents progression towards the goal without goal attainment; ''0'' is the expected level after treatment, (and therefore, the ''most likely'' level after treatment); ''+1'' represents a better outcome than expected; ''+2'' is the best possible outcome that could have been expected for this goal.

    Measured: Baseline to 6-months post-intervention: two times per week during baseline and intervention phase for each chosen-goal ; one time at 2, 4 and 6-months post-intervention.

Secondary outcomes (3)
  1. Canadian Occupational Performance Measure (COPM)

    The Canadian Occupational Performance Measure is an individualized, client--centered, semi--structured interview used to identify occupational performance issues.For each performance issue, perceived performance and satisfaction are scored on a 1 to 10 Likert scale.

    Performance and satisfaction are rated by children and parents on a scale of 1 to 10 (1= not at all able to perform the activity (performance) / not at all satisfied with the way the activity is performed (satisfaction); 10 = perfectly able to perform the activity (performance) / perfectly satisfied with the way the activity is performed (satisfaction). A difference of 2 points between pre- and post-intervention is clinically significant.

    For each self--identified goal, four different COPM ratings will be obtained: (1) the participant's perceived occupational performance rating; (2) the participant's satisfaction rating; (3) the parent's perceived occupational performance rating; (4) the parent's satisfaction rating.

    Measured: Once before baseline, at immediate post-intervention, at 2, 4 and 6-months post-intervention.

  2. Behavior Rating Inventory of Executive Function questionnaire (BRIEF)

    The Behavior Rating Inventory of Executive Function questionnaire (BRIEF, or BRIEF-A for adults'version) provide an ecological assessment of executive functioning through its repercussions in family and school context. Currently, this questionnaire is the best validated and most widely used in children in various congenital, developmental or acquired conditions. The outcome measure is the Global Executive Composite score (GEC) T-Scores (Mean: 50; SD: 10; clinical range cutoff: T-Scores≥65).

    Measured: twice in baseline, once in immediate post-intervention and once at 2,4,6 month post-intervention.

  3. Entretien Engagement des Proches

    The aim of this interview is to collect information on the experience of use of CO-OP by family caregivers with the participant, outside of rehabilitation sessions. No scale of score, the interviews will be analyzed according to a qualitative description.

    Measured: once at immediate post-intervention, 4 and 6 months-post-intervention]

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start1 Sep 2025 (estimated)
  3. Primary completion1 May 2027 (estimated)
  4. Study completion1 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
replicated single case experimental study using a randomized multiple baseline design across participants and goals
Masking
None (open label)
Enrolment
12 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07085403
Sponsor's protocol ID
COOPerons - PR- 2024 - 7
Status last verified
Aug 2025
First submitted
4 Jul 2025
Last updated
13 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Steenbeek D, Ketelaar M, Galama K, Gorter JW. Goal Attainment Scaling in paediatric rehabilitation: a report on the clinical training of an interdisciplinary team. Child Care Health Dev. 2008 Jul;34(4):521-9. doi: 10.1111/j.1365-2214.2008.00841.x.

    PubMed 19154553
  • Polatajko HJ, Mandich AD, Missiuna C, Miller LT, Macnab JJ, Malloy-Miller T, Kinsella EA. Cognitive orientation to daily occupational performance (CO-OP): part III--the protocol in brief. Phys Occup Ther Pediatr. 2001;20(2-3):107-23.

    PubMed 11345506

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Orientation to daily Occupational Performance (CO-OP) is a cognitive problem-solving approach in people with Executive Function Deficits (EFD) and Developmental Coordination Disorder, run by Hopitaux de Saint-Maurice at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Helene LEBRAULT, OT, PhD (+0033143966682, helene.lebrault@ght94n.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Goal Attainment Scale (GAS) (time frame: Baseline to 6-months post-intervention: two times per week during baseline and intervention phase for each chosen-goal ; one time at 2, 4 and 6-months post-intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07085403, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in